PEDRO PIEDRA to Orthomyxoviridae
This is a "connection" page, showing publications PEDRO PIEDRA has written about Orthomyxoviridae.
Connection Strength
0.914
-
Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan. BMC Pediatr. 2023 01 21; 23(1):35.
Score: 0.201
-
Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children. Semin Pediatr Infect Dis. 2002 Apr; 13(2):90-6.
Score: 0.190
-
Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment. Clin Infect Dis. 2022 02 11; 74(3):532-540.
Score: 0.188
-
Remote Laboratory Management: Respiratory Virus Diagnostics. J Vis Exp. 2019 04 06; (146).
Score: 0.155
-
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. 2015 May 15; 211(10):1529-40.
Score: 0.114
-
Influenza virus pneumonia: pathogenesis, treatment, and prevention. Semin Respir Infect. 1995 Dec; 10(4):216-23.
Score: 0.031
-
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014 Feb; 58(3):319-27.
Score: 0.027
-
Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med. 1997 Mar 17; 102(3A):61-70; discussion 75-6.
Score: 0.008